Skip to main content

Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne (PAPA) Syndrome

  • Living reference work entry
  • First Online:
Encyclopedia of Medical Immunology

Synonyms

CD2-binding protein 1; CD2BP1; PAPA; Proline-serine-threonine phosphatase-interacting protein 1; PSTPIP1; Pyogenic arthritis, pyoderma gangrenosum, and acne

Definition

Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome is a rare autoinflammatory condition presenting with inflammatory joint and skin disease that is caused by autosomal dominant, gain-of-function mutations in PSTPIP1 (MIM #604416).

Introduction

PAPA syndrome was first described in a large family in 1997 (Lindor et al. 1997). The “streaky leukocyte syndrome” described in a teenage boy in 1975 was later confirmed by genetic testing to be a case of PAPA syndrome (Jacobs and Goetzl 1975).

Genetics

Familial PAPA syndrome is inherited in an autosomal dominant manner with phenotypic variability. De novo mutations are the cause of PAPA syndrome in other individuals. PAPA syndrome results from mutations in PSTPIP1 (proline-serine-threonine phosphatase-interacting protein 1), also known as CD2-binding...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Holzinger D Roth J. Alarming consequences – autoinflammatory disease spectrum due to mutations in proline-serine-threonine phosphatase-interacting protein 1. Curr Opin Rheumatol. 2016;28(5):550–559. PubMed: 27464597.

    Google Scholar 

  • Jacobs JC, Goetzl EJ. ‘Streaking leukocyte factor,’ arthritis and pyoderma gangrenosum, Pediatrics. 1975;56:570–578. PubMed: 1165961.

    Google Scholar 

  • Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT. A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum and acne: PAPA syndrome. Mayo Clin Proc. 1997; 72:611–615. PubMed: 9212761.

    Google Scholar 

  • Omenetti A, Carta S, Caorsi R, Finetti M, Marotto D, Lattanzi B et al. Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome Rheumatology (Oxford). 2016; 55(7):1325–1335. PubMed: 26989109.

    Google Scholar 

  • Shoham NG, Centola M, Mansfield E, Hull KM, Wood G, Wise CA, et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci U S A. 2003;100:13501–13506. PubMed: 14595024.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deborah L. Stone .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Stone, D.L., Kastner, D.L. (2019). Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne (PAPA) Syndrome. In: MacKay, I., Rose, N. (eds) Encyclopedia of Medical Immunology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9209-2_128-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9209-2_128-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-9209-2

  • Online ISBN: 978-1-4614-9209-2

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics